Murchinson’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Murchinson’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-800,000	Closed	-$96K	–	81
2022 Q3	$96K	Hold	800,000	–	–	0.03%	47
2022 Q2	$64K	Hold	800,000	–	–	0.01%	71
2022 Q1	$96K	Hold	800,000	–	–	0.02%	80
2021 Q4	$153K	Hold	800,000	–	–	0.01%	93
2021 Q3	$168K	Hold	800,000	–	–	0.08%	70
2021 Q2	$216K	Buy	+800,000	New	+$165K	0.08%	88

Other funds holding VHAQ.RT

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Murchinson's VHAQ.RT Position: Q4 2022 in Review

Murchinson sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q4 2022, closing a stake of 800,000 shares — an estimated $96K sold.

Murchinson first reported a position in VHAQ.RT in Q2 2021 and held it in 6 quarters. The position peaked at $216K in Q2 2021. 27 funds tracked by Wall St. Rank hold VHAQ.RT as of Q4 2022.

Murchinson reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q4 2022 after selling out during the quarter.
Murchinson sold 800,000 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q4 2022, an estimated $96K.
Murchinson first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q2 2021 and held it in 6 quarters.
Murchinson's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $216K in Q2 2021.
27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q4 2022.

Based on Murchinson's 13F filing for Q4 2022, filed 10 Feb 2023.